although
bioinformat
gener
perceiv
modern
scienc
term
put
forward
thirti
year
ago
paulien
hogeweg
ben
hesper
studi
informat
process
biotic
system
hogeweg
hogeweg
hesper
necessarili
nebulousbioinformat
span
mani
disciplin
mani
shade
mean
inde
argu
collat
analysi
data
differ
disciplin
provid
greatest
insight
field
genom
transcriptom
bioinformat
incred
divers
field
evolut
epidemiolog
ecolog
respons
organ
environ
field
requir
bioinformat
accur
process
place
context
variou
sourc
data
heart
genom
transcriptom
gener
analysi
vast
quantiti
sequenc
data
dna
sequenc
took
late
appli
biosystem
develop
first
autom
sequenc
machin
subsequ
develop
effici
way
sequenc
result
phenomen
growth
number
sequenc
deposit
genbank
figur
obvious
million
sequenc
deposit
genbank
feasibl
seriou
manual
work
larg
dataset
data
obtain
modern
secondgener
sequenc
order
time
greater
capillarybas
sequenc
possibl
routin
gener
mani
gigabas
sequenc
data
bioinformat
task
make
sens
mine
store
dissemin
ensur
valid
biolog
conclus
drawn
mani
recent
highthroughput
function
genom
technolog
reli
bioinformat
compon
though
bioinformat
one
part
process
exampl
identif
protein
mass
spectroscopi
quantit
analysi
express
data
phylogenet
make
use
bioinformat
tool
method
databas
bioinformat
play
key
role
sever
step
genom
compar
genom
function
genom
sequenc
align
assembl
identif
singl
nucleotid
polymorph
snp
gene
predict
quantit
analysi
transcript
data
etc
chapter
discuss
current
state
play
bioinformat
relat
genom
transcriptom
use
relev
exampl
field
infecti
diseas
term
metagenom
origin
use
describ
sequenc
genom
uncultur
microorgan
order
explor
abil
produc
natur
product
handelsman
et
al
rondon
et
al
subsequ
result
novel
insight
ecolog
evolut
microorgan
scale
imagin
possibl
see
cardena
tiedj
hugenholtz
tyson
overview
howev
metagenom
find
use
infecti
diseas
research
well
random
sequenc
genom
varieti
organ
exampl
patient
materi
could
lead
identif
caus
diseas
quit
straightforward
metagenom
approach
identifi
pathogen
sputa
cystic
fibrosi
patient
standard
microbiolog
cultur
techniqu
compar
molecular
method
use
rdna
pcr
bittar
et
al
wellknown
disadvantag
microbiolog
method
normal
employ
select
media
design
pick
bacteri
pathogen
thought
present
emerg
pathogen
miss
use
tradit
cultur
techniqu
inde
bittar
et
al
identifi
bacteria
use
cultiv
bacteri
speci
detect
use
molecular
method
base
blast
comparison
altschul
et
al
interestingli
latter
anaerob
organ
miss
routin
cultiv
method
mani
bacteria
identifi
use
molecular
method
tradit
thought
associ
cystic
fibrosi
whether
novel
speci
associ
physiopatholog
diseas
remain
studi
bittar
et
al
also
note
number
bacteria
detect
increas
increas
number
clone
sequenc
wellknown
phenomenon
environment
sequenc
relat
sampl
depth
huber
et
al
huse
et
al
howev
increas
use
nextgener
sequenc
method
infecti
diseas
research
lesson
learn
environment
studi
relat
divers
rel
abund
differ
microb
put
effect
use
exampl
use
secondgener
sequenc
metagenom
approach
patient
materi
studi
nakamura
et
al
identifi
virus
nasal
fecal
materi
studi
rna
isol
patient
materi
obtain
season
influenza
infect
noroviru
outbreak
rna
revers
transcrib
cdna
subsequ
subject
largescal
parallel
pyrosequenc
result
read
averag
per
sampl
although
influenza
sampl
mainli
human
origin
nonetheless
possibl
identifi
influenza
subtyp
sampl
nakamura
et
al
fecal
sampl
clear
human
bacteri
cell
yield
much
better
complet
noroviru
subtyp
genom
sequenc
averag
cover
depth
addit
abl
identifi
influenza
norovirus
two
recent
identifi
human
virus
also
identifi
wu
polyomaviru
human
coronaviru
nakamura
et
al
major
bacteri
speci
normal
found
respiratori
tract
also
identifi
although
nakamura
et
al
suggest
highthroughput
sequenc
sensit
standard
pcrbase
analysi
might
result
detect
addit
possibl
pathogen
also
warn
increas
sensit
might
necessit
followup
work
decid
detect
pathogen
actual
caus
diseas
import
result
expect
human
microbiom
project
http
wwwhmpdaccorg
obtain
metagenom
inform
variou
human
microenviron
gastrointestin
nasoor
urogenit
caviti
well
skin
understand
human
microbiom
thought
answer
question
whether
chang
human
microbiom
relat
human
health
howev
largescal
metagenom
project
includ
eukaryot
genom
thu
far
quit
costli
labori
due
gener
larg
genom
eukaryot
lower
sequenc
cost
may
allevi
part
problem
sequenc
data
still
accumul
faster
rate
develop
comput
analysi
hugenholtz
tyson
organ
attract
attent
genom
center
caus
diseas
follow
model
organ
saccharomyc
cerevisia
goffeau
et
al
caenorhabd
elegan
c
elegan
sequenc
consortium
exampl
inde
first
bacteri
genom
sequenc
pathogen
fraser
et
al
tomb
et
al
preced
mani
bacteriophag
genom
bacteriophag
fier
et
al
sanger
et
al
viral
genom
fier
et
al
current
pathogen
genom
repres
least
one
third
sequenc
genom
obvious
compar
genom
two
genom
requir
inde
second
bacteri
pathogen
sequenc
mycoplasma
genitalium
fraser
et
al
immedi
compar
first
one
haemophilu
influenza
fleischmann
et
al
interestingli
h
influenza
genom
complet
use
bioinformat
approach
unlik
previou
sequenc
project
use
shotgun
approach
reli
comput
justif
suffici
random
sequenc
small
fragment
would
result
complet
coverag
whole
genom
compar
genitalium
genom
haemophilu
genom
suggest
percentag
total
genom
dedic
gene
similar
albeit
genitalium
far
fewer
gene
fraser
et
al
although
genom
genitalium
three
time
smaller
h
influenza
smaller
genom
result
increas
gene
densiti
decreas
gene
size
detect
sever
repeat
compon
mycoplasma
adhesin
elicit
strong
immun
respons
human
suggest
recombin
might
underli
abil
evad
human
immun
respons
initi
genom
studi
tip
compar
genom
iceberg
alreadi
clear
fleischmann
et
al
last
sentenc
knowledg
complet
genom
pathogen
organ
could
lead
new
vaccin
wholegenom
effort
identifi
vaccin
candid
appear
year
later
pizza
et
al
employ
bioinformat
extract
put
surfaceexpos
antigen
genom
analysi
although
effect
vaccin
neisseria
meningitidi
caus
agent
meningococc
mening
sepsi
exist
vaccin
cover
pathogen
serogroup
serogroup
b
evad
develop
good
vaccin
capsular
polysaccharid
vaccin
serogroup
develop
ident
human
carbohydr
order
identifi
put
candid
vaccin
develop
pizza
et
al
decid
sequenc
whole
genom
serogroup
b
strain
potenti
open
read
frame
orf
analyz
put
cellular
locat
use
blastx
orf
like
cytosol
exclud
analysi
remain
orf
analyz
determin
whether
encod
protein
contain
transmembran
domain
leader
peptid
outer
membran
anchor
motiv
use
varieti
databas
pfam
finn
et
al
prodom
servant
et
al
result
orf
encod
put
expos
antigen
put
gene
clone
escherichia
coli
pizza
et
al
success
express
orf
recombin
protein
use
gener
antisera
test
enzymelink
immunosorb
assay
elisa
fluorescenceactiv
cell
sorter
fac
analys
test
whether
detect
protein
outer
surfac
serogroup
b
meningococcu
strain
addit
sera
test
bactericid
activ
protein
react
posit
least
one
assay
posit
three
assay
subsequ
test
larg
varieti
strain
analyz
efficaci
total
seem
abl
provid
protect
n
meningitidi
strain
addit
protein
similar
homolog
n
gonorrhoea
protein
suggest
might
provid
success
protect
pathogen
well
pizza
et
al
arguabl
strike
aspect
studi
month
author
identifi
vaccin
candid
preced
year
use
novel
genomicsbioinformat
approach
seib
et
al
studi
result
vaccin
current
phase
iii
clinic
trial
giuliani
et
al
protozoan
infect
major
burden
develop
nation
take
diseas
target
world
health
organ
special
program
research
train
tropic
diseas
http
wwwwhointtdr
last
year
parasit
genom
sequenc
hope
sequenc
would
reveal
weak
spot
target
pathogen
trypanosomatid
caus
seriou
diseas
africa
south
america
trypanosoma
brucei
caus
sleep
sick
human
wast
diseas
cattl
trypanosoma
cruzi
caus
agent
chaga
diseas
leishmania
major
lead
skin
lesion
complet
genom
elsay
et
al
iven
et
al
compar
analysi
three
genom
elsay
et
al
may
abl
focu
effort
toward
obtain
vaccin
current
drug
seriou
toxic
issu
although
genom
encod
differ
number
proteinencod
gene
around
brucei
l
major
cruzi
compar
analysi
result
identif
gene
entail
trypanosomatid
core
proteom
protein
code
gene
compar
threeway
manner
use
blastp
elsay
et
al
mutual
best
hit
group
cluster
ortholog
gene
cog
figur
trypanosomatid
specif
protein
might
use
broadscal
vaccin
remaind
proteinencod
gene
parasit
gene
brucei
l
major
cruzi
consist
speciesspecif
gene
interestingli
larg
proport
gene
encod
surfac
antigen
might
relat
differ
mechan
parasit
employ
evad
host
immun
system
addit
note
mani
gene
encod
surfac
antigen
found
near
telomer
mani
retroel
seem
present
region
well
might
relat
enorm
antigen
variat
observ
trypanosoma
speci
presenc
novel
gene
area
might
suggest
product
play
unknown
role
antigen
variat
well
warrant
studi
uncharacter
gene
elsay
et
al
detail
knowledg
wellstudi
pathogen
might
success
use
understand
biolog
close
relat
emerg
pathogen
drive
forc
sequenc
six
candida
speci
butler
et
al
candida
speci
common
opportunist
fungal
infect
world
c
albican
common
candida
speci
caus
infect
howev
c
albican
incid
declin
speci
emerg
comparison
eight
candida
speci
indic
although
genom
size
variabl
gene
content
nearli
ident
across
speci
analysi
includ
pathogen
nonpathogen
speci
butler
et
al
specif
studi
differ
two
group
gene
famili
analyz
significantli
enrich
pathogen
speci
mani
gene
famili
known
involv
pathogenesi
present
famili
eg
lipas
oligopeptid
transport
adhesin
interestingli
sever
poorli
character
gene
famili
also
identifi
suggest
might
play
unexpect
role
pathogenesi
well
compar
studi
reveal
wealth
new
avenu
explor
combin
larg
bodi
work
perform
c
albican
aid
understand
newli
emerg
pathogen
candida
speci
butler
et
al
although
compar
studi
use
multipl
speci
reveal
hitherto
unknown
featur
evidenc
mention
trypanosomatid
candida
studi
also
reveal
someth
unexpect
definit
bacteri
speci
debat
long
time
tettelin
et
al
set
address
question
sequenc
multipl
strain
streptococcu
agalactia
common
caus
ill
death
among
newborn
unexpectedli
despit
presenc
coregenom
share
genom
mathemat
model
suggest
addit
sequenc
genom
would
add
new
gene
dispens
genom
addit
analysi
use
pyogen
also
suggest
sequenc
addit
genom
would
continu
add
new
gene
pool
result
pangenom
defin
global
gene
repertoir
speci
extrapol
ad
infinitum
similar
analysi
bacillu
anthraci
indic
fourth
genom
addit
gene
identifi
agreement
known
limit
genet
divers
keim
smith
subsequ
analys
confirm
presenc
pangenom
mani
bacteri
speci
hiller
et
al
stanhop
rasko
et
al
schoen
et
al
stanhop
ultim
gene
repertoir
bacteri
speci
much
larger
gener
perceiv
whether
would
case
eukaryot
remain
shown
despit
appar
everexpand
possibl
pangenom
also
result
univers
vaccin
candid
group
b
streptococcu
gb
variou
gb
serotyp
exist
current
vaccin
offer
protect
limit
set
serotyp
eight
genom
six
serotyp
compar
result
identif
coregenom
gene
dispens
genom
gene
present
strain
genom
analyz
presenc
put
surfaceassoci
secret
protein
identifi
gene
one
third
part
dispens
genom
gene
author
subsequ
produc
recombin
tag
protein
e
coli
use
immun
mice
ultim
combin
four
antigen
turn
highli
effect
major
gb
serotyp
three
antigen
part
dispens
genom
addit
bioinformat
approach
highlight
import
dismiss
unidentifi
orf
genom
gener
sequenc
genom
four
antigen
assign
function
identif
use
method
becam
obviou
part
piluslik
structur
never
seen
group
b
streptococcu
lauer
et
al
presenc
antigen
provid
protect
piluslik
structur
suggest
might
play
role
pathogen
genom
inform
use
scaffold
howev
given
environ
pathogen
host
express
subset
gene
one
time
presenc
pangenom
complic
matter
even
investig
respons
organ
environment
stress
necessari
examin
express
pattern
protein
present
possibl
accomplish
directli
larg
scale
good
approxim
made
sequenc
count
mrna
molecul
present
process
involv
convert
rna
cdna
introduc
bias
nonetheless
sequenc
great
mani
advantag
tradit
microarray
ledford
includ
high
specif
littl
background
nois
one
also
gain
nucleotid
level
resolut
express
despit
drawback
microarray
still
extrem
power
tool
understand
level
gene
express
obviou
studi
toledoarana
et
al
discov
novel
regulatori
mechan
listeria
toledoarana
et
al
l
monocytogen
normal
harmless
lead
seriou
foodborn
infect
environment
chang
soil
stomach
intestin
lumen
ultim
bloodstream
thought
respons
upand
downregul
plethora
gene
compar
genom
nonpathogen
l
innocua
result
identif
virul
locu
glaser
et
al
use
microarray
transcript
one
strain
grown
c
rich
medium
compar
three
differ
condit
stationari
phase
hypoxia
low
temperatur
c
addit
knockout
mutant
three
known
regul
listeria
virul
gene
express
prfa
sigb
hfq
compar
control
strain
well
rna
also
extract
intestin
inocul
mice
blood
healthi
human
donor
infect
three
differ
strain
control
prfa
sigb
knockout
analysi
result
discoveri
massiv
transcript
reshap
control
sigb
listeria
enter
intestin
howev
bloodstream
gene
express
control
prfa
variou
noncod
rna
uncov
show
express
patter
virul
gene
suggest
potenti
role
virul
toledoarana
et
al
microarray
data
base
compar
differ
hybrid
highthroughput
nextgener
sequenc
seen
quantit
base
number
hit
sequenc
transcript
van
vliet
howev
make
cdna
nextgener
sequenc
transcriptom
prokaryot
sever
difficulti
found
eukaryot
high
level
rrna
trna
molecul
well
lack
polya
tail
make
extract
difficult
nontheless
possibl
overcom
either
reduc
amount
rrna
trna
use
commerci
avail
kit
bioinformat
remov
sequenc
postsequenc
van
vliet
date
rnaseq
style
experi
perform
prokaryot
give
exampl
sort
novel
insight
glean
use
technolog
passalacqua
et
al
sequenc
bacillu
anthraci
transcriptom
use
solid
illumina
sequenc
clearli
show
polycistron
natur
mani
transcript
whole
genom
scale
although
known
individu
operon
never
shown
genomewid
scale
also
abl
test
current
genom
annot
discov
loci
remov
nongen
show
signific
transcript
activ
addit
nonannot
region
clear
level
transcript
therefor
consid
gene
passalacqua
et
al
intern
methionin
could
incident
identifi
start
codon
also
check
whether
upstream
region
includ
transcrib
region
case
prove
case
suggest
origin
start
codon
incorrectli
annot
reassuringli
compar
data
microarray
data
strong
correl
observ
interestingli
high
resolut
sequencebas
transcriptom
studi
possibl
identifi
novel
regulatori
element
exampl
compar
express
level
co
rich
condit
first
gene
eightgen
operon
show
mark
differ
express
level
other
significantli
upregul
co
passalacqua
et
al
inde
bioinformat
approach
suggest
presenc
tbox
riboswitch
gene
operon
griffithsjon
et
al
similar
approach
studi
burkholderia
cenocepacia
opportunist
cystic
fibrosi
pathogen
respond
environment
chang
reveal
sever
new
potenti
virul
factor
yoderhim
et
al
b
cenocepacia
routin
isol
soil
two
strain
one
isol
cystic
fibrosi
patient
one
soil
analyz
respons
chang
growth
synthet
human
sputum
medium
soil
medium
although
overal
nucleotid
ident
homolog
gene
show
signific
differ
express
two
strain
grown
synthet
sputum
medium
soil
medium
respect
suggest
despit
high
level
related
differenti
gene
express
play
larg
role
adapt
ecolog
nich
yoderhim
et
al
interestingli
similar
passalacqua
et
al
sever
express
noncod
rna
uncov
differ
express
level
depend
environment
condit
signific
need
investig
highlight
abil
secondgener
sequenc
unearth
novel
find
despit
fact
speci
genom
could
well
larger
actual
genom
content
one
member
speci
due
pangenom
concept
organ
proteom
far
much
complex
discuss
earlier
transcriptom
reveal
subset
genom
express
given
condit
howev
posttransl
modif
protein
make
actual
proteom
far
complex
transcriptom
also
strength
proteom
seen
studi
oblig
intracellular
parasit
chlamydia
pneumonia
c
pneumonia
thirdmostcommon
caus
respiratori
infect
world
part
made
possibl
due
uniqu
biphas
life
cycl
bacteri
pathogen
chlamydia
spread
via
metabol
inert
infecti
particl
call
elementari
bodi
elementari
bodi
enter
host
cell
differenti
reticul
bodi
elementari
bodi
infecti
phase
protein
present
outer
membran
would
ideal
candid
vaccin
develop
especi
effect
vaccin
lack
treatment
via
antibiot
therapi
largescal
genomicsproteom
studi
montigiani
et
al
systemat
assess
put
expos
antigen
possibl
use
vaccin
develop
c
pneumonia
gene
assign
function
latter
predict
peripher
locat
therefor
select
followup
studi
addit
remain
orf
subject
seri
search
algorithm
aim
identifi
put
surfaceexpos
antigen
total
orf
identifi
possibl
locat
cell
surfac
subsequ
use
produc
recombin
protein
e
coli
histag
well
gsttag
version
made
total
recombin
protein
produc
use
immun
mice
antisera
use
fac
analysi
test
could
bind
c
pneumonia
cell
surfac
result
identif
put
surfaceexpos
antigen
interestingli
apart
wellknown
antigen
antigen
unidentifi
orf
part
group
potenti
vaccin
candid
candid
test
western
blot
whether
gener
clean
band
expect
size
whether
crossreact
protein
specif
final
montigiani
et
al
conduct
proteom
analysi
total
protein
elementari
bodi
phase
identifi
spot
use
mass
spectrometri
protein
sequenc
use
malditof
identifi
put
surfaceexpos
antigen
c
pneumonia
gel
montigiani
et
al
followup
studi
thorp
et
al
clearli
show
one
identifi
candid
lcre
induc
amongst
other
cell
activ
complet
clear
infect
murin
model
interestingli
lcre
homolog
protein
thought
part
type
iii
secret
system
yersinia
expos
natur
lcre
c
pneumonia
cell
surfac
suggest
type
iii
secret
system
play
role
chlamydia
infect
montigiani
et
al
import
expos
outer
membran
protein
potenti
vaccin
candid
prompt
berlanda
scorza
et
al
assess
complement
outer
membran
protein
extraintestin
pathogen
e
coli
strain
berlanda
scorza
et
al
extraintestin
pathogen
e
coli
lead
caus
sever
sepsi
current
increas
drug
resist
warrant
search
novel
vaccin
target
addit
current
wholecel
vaccin
suffer
undesir
crossreact
commens
e
coli
well
novel
approach
berland
scorza
et
al
base
observ
gramneg
bacteria
releas
outer
membran
vesicl
omv
cultur
media
albeit
minut
quantiti
tolr
mutant
appear
releas
much
omv
wildtyp
cell
subsequ
largescal
mass
spectroscop
analysi
protein
content
result
identif
protein
major
outer
membran
periplasm
protein
intriguingli
three
subunit
cytoleth
distend
toxin
cdt
includ
toxin
unusu
one
subunit
target
eukaryot
host
cell
break
doublestrand
dna
result
cell
death
de
ryck
oswald
check
whether
presenc
cdt
omv
due
tolr
knockout
wildtyp
extraintestin
pathogen
e
coli
test
use
western
blot
inde
cdt
detect
wildtyp
omv
well
berlanda
scorza
et
al
suggest
toxin
deliveri
via
vesicl
might
well
key
event
pathogenesi
interestingli
identifi
protein
predict
target
periplasm
outer
membran
psortb
gardi
et
al
see
excel
opportun
train
protein
target
algorithm
new
wetbench
data
algorithm
gener
train
limit
set
model
organ
reflect
divers
encount
real
life
despit
enorm
progress
genom
infecti
diseas
discoveri
new
drug
kept
equal
pace
exampl
candid
drug
identifi
highthroughput
screen
use
valid
bacteri
drug
target
payn
et
al
although
broadspectrum
drug
might
desir
recent
trend
target
specif
protein
specif
pathogen
use
structur
biolog
sever
structur
genom
initi
set
target
specif
group
pathogen
exampl
seattl
structur
genom
center
infecti
diseas
http
ssgcidorg
center
structur
genom
infecti
diseas
http
wwwcsgidorg
work
categori
c
agent
list
nation
institut
allergi
infecti
diseas
niaid
center
focu
specif
organ
mycobacterium
tuberculosi
exampl
mycobacterium
tuberculosi
structur
proteom
project
http
xmtb
org
mycobacterium
tuberculosi
structur
proteom
consortium
http
wwwdoembiuclaedutb
field
structur
genom
aim
solv
mani
protein
structur
possibl
human
pathogen
aim
come
new
drug
target
vaccin
van
voorhi
et
al
obvious
correct
select
candid
structur
genom
project
paramount
variou
criteria
put
forward
anderson
van
voorhi
et
al
protein
alreadi
valid
drug
target
obvious
aid
select
protein
need
essenti
pathogen
ideal
absent
human
protein
involv
uptak
essenti
nutrient
anoth
target
classic
drug
design
focus
substrat
bind
site
recent
small
molecul
interf
subunit
bind
start
attract
attent
eukaryot
prokaryot
inorgan
pyrophosphatas
differ
composit
former
homodim
latter
homohexam
effort
aim
compound
interfer
oligomer
state
enzym
contrast
highli
conserv
activ
site
inorgan
pyrophosphatas
would
good
target
van
voorhi
et
al
sar
outbreak
caught
infecti
diseas
commun
whole
world
surpris
one
exampl
structur
genom
made
enorm
progress
despit
know
coronavirus
caus
seriou
diseas
anim
fact
caus
mild
diseas
human
meant
littl
knowledg
coronaviru
biolog
subsequ
effort
understand
viral
assembl
replicationtranscript
exampl
result
elucid
sarscov
solv
protein
structur
interestingli
novel
folddiscoveri
rate
nearli
would
normal
close
bartlam
et
al
addit
one
key
protein
sarscov
main
proteas
sinc
center
structurebas
drug
discoveri
natur
disciplin
structur
genom
depend
variou
disciplin
biochemistri
microbiolog
structur
biolog
comput
biolog
bioinformat
foster
truli
interdisciplinari
environ
anderson
possibl
sequenc
entir
genom
bacteri
pathogen
assembl
raw
sequenc
read
perform
autom
annot
visual
result
within
week
time
inde
even
sequenc
also
possibl
select
sequenc
transcriptom
rnaseq
region
dna
bound
protein
chipseq
relev
speci
methyl
dna
studi
epigenet
effect
well
small
rna
molecul
also
possibl
perform
sequenc
host
organ
time
bioinformat
algorithm
tool
crucial
tool
analyz
unpreced
volum
data
data
volum
emerg
result
secondgener
sequenc
illumina
abisolid
system
although
use
inform
extract
singl
research
target
analysi
sequenc
output
gain
inform
data
becom
increasingli
common
multipl
research
research
group
wide
differ
area
expertis
collabor
collabor
absolut
crucial
relev
insight
gain
largescal
dataset
result
vast
array
data
gener
requir
annot
curat
well
analyz
inform
relev
particular
experi
addit
inform
need
store
share
distribut
manner
enabl
reanalysi
new
hypothes
gener
platform
produc
gmod
consortium
http
gmodorg
gbrows
underli
databas
excel
webbas
tool
visual
compar
dataset
howev
current
offer
limit
scope
collabor
annot
curat
dataset
relev
expertis
brought
bear
varieti
differ
research
group
problem
magnifi
advent
secondgener
sequenc
sinc
much
smaller
group
research
tend
involv
mean
expertis
larg
collabor
muster
influenza
research
databas
fludb
http
wwwfludborg
much
smaller
thu
need
integr
annot
visual
pipelin
enabl
individu
research
perform
compar
genom
transcriptom
broad
institut
offer
number
use
visual
tool
individu
research
argo
http
wwwbroadinstituteorgannotationargo
integr
genom
viewer
igv
http
wwwbroadinstituteorgigv
argo
offer
abil
manual
annot
visual
genom
well
provid
good
graphic
overview
compar
genom
transcriptom
current
one
standard
bioinformat
pipelin
develop
nextgener
sequenc
sever
effort
underway
adapt
sanger
sequenc
pipelin
includ
prokaryot
annot
pipelin
xbase
isga
server
hemmerich
et
al
enabl
de
novo
sequenc
prokaryot
genom
annot
automat
correct
manual
later
date
altern
sanger
adapt
maker
also
use
assembl
gener
larg
array
program
avail
either
align
read
refer
genom
assembl
de
novo
miller
et
al
paszkiewicz
studholm
list
detail
mani
consider
includ
sequenc
platform
use
read
length
use
expect
genom
size
length
longest
repetit
element
gc
content
whether
pairedend
read
use
proprietari
newbler
softwar
roch
popular
method
de
novo
assembl
read
typic
popular
assembl
short
read
ie
mostli
illumina
solid
platform
velvet
http
wwwebiacukbzerbinovelvet
assembl
genom
dna
oas
group
deal
assembl
read
transcriptom
cdna
http
wwwebiacukbzerbinooas
zerbino
birney
assembl
abyss
simpson
et
al
allpath
butler
et
al
soapdenovo
http
soapgenomicsorgcnsoapdenovohtml
also
popular
abyss
enabl
assembl
parallel
thu
speed
assembl
allpath
shown
offer
superior
perform
multipl
pairedend
librari
use
independ
read
length
crucial
pairedend
librari
use
construct
de
novo
assembl
genom
note
use
shortread
sequenc
lead
signific
gap
left
final
assembl
due
repetit
element
howev
mani
analys
especi
prokaryot
organ
gap
gener
consid
signific
case
closur
gap
desir
addit
sanger
longrang
pcr
data
often
help
signific
quantiti
longand
shortread
data
avail
joint
assembl
attempt
recommend
protocol
assembl
short
long
read
separ
use
respect
packag
merg
two
assembl
use
program
minimu
sommer
et
al
anoth
option
use
templat
sequenc
relat
organ
help
guid
assembl
notethi
distinct
remap
describ
amoscmp
packag
use
purpos
pop
et
al
final
whatev
assembl
method
use
import
rememb
longer
assembl
necessarili
better
one
examin
read
make
contig
eg
use
amo
packag
http
amossourceforgenet
tablet
viewer
http
bioinfscriacuktablet
align
coreconserv
group
gene
standard
practic
ensur
blatant
error
correct
remap
short
read
refer
genom
also
valid
method
comparison
although
softwar
blat
kent
use
longer
read
ideal
tool
shorter
read
technolog
data
volum
much
greater
genom
avail
softwar
maq
successor
bwa
bowti
soap
other
offer
wealth
tool
identifi
indel
snp
variant
may
interest
crucial
case
import
suffici
depth
coverag
ensur
snp
call
valid
pairedend
data
also
valuabl
highlight
presenc
indel
remap
also
common
practic
assembl
unmap
read
use
de
novo
assembl
softwar
reveal
novel
sequenc
variant
may
absent
refer
case
pathogen
host
sequenc
togeth
sequenc
least
one
known
rel
straightforward
separ
two
use
bioinformat
techniqu
deal
transcriptom
data
refer
sequenc
avail
softwar
erang
http
woldlabcaltechedurnaseq
tophat
trapnel
et
al
cufflink
http
cufflinkscbcbumdedu
extrem
use
cufflink
modul
particular
offer
abil
predict
like
exon
isoform
express
pattern
use
combin
bayesian
statist
graphbas
algorithm
awar
treatment
use
omic
bioinformat
infecti
diseas
research
exhaust
mention
introduct
constitut
bioinformat
entir
clear
arguabl
vari
depend
tri
defin
howev
attempt
show
consider
progress
infecti
diseas
research
made
recent
year
use
variou
omic
case
studi
addit
last
section
attempt
provid
brief
overview
problem
bioinformat
solut
currentday
scientist
face
embark
secondgener
sequenc
strategi
fastmov
field
provid
refer
websit
good
first
approach
wish
make
stride
toward
erad
infecti
diseas
planet
